Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Faron Pharmaceuticals Ltd on Wednesday reported positive data from an ongoing trial on patients receiving a new treat ...
Faron Pharmaceuticals Oy 27 November 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Inside Information: Faron Announces Positive Phase 2 Interim Results from BEXMAB Trial to...
Faron Pharmaceuticals Oy 05 November 2024 ("Faron" or "the Company") Composition of Faron Pharmaceutical's Shareholders' Nomination Board Company Announcement, 5 November 2024 TURKU...
Faron Pharmaceuticals Oy 22 October 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron's Capital Markets Day 2024 - BEXMAB follow-up data and update on drug development...
Faron Pharmaceuticals Oy 30 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Grant of options Company announcement, August 30, 2024 TURKU, FINLAND - Faron...
Faron Pharmaceuticals Ltd on Tuesday said its loss widened in the first half of 2024, as the company successfully adv ...
Faron Pharmaceuticals Oy 26 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Inside Information: FDA Grants Fast Track Designation for Bexmarilimab in r/r MDS ...
Faron Pharmaceuticals Oy 27 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or "the Company") Faron Reports Half-Year Financial Results, 1 January - 30 June 2024 Company Announcement...
Faron Pharmaceuticals Oy 20 August 2024 Faron Pharmaceuticals Ltd. ("Faron" or the "Company") Faron Pharmaceuticals Notice of Half-Year Financial Results Company Announcement, 20 August...
cals Ltd - Turku, Finland-based clinical-stage biopharmaceutical maker - Joins consortium that has received a USD1.5 m ...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 35 | 22.9508196721 | 152.5 | 187.5 | 152.5 | 46567 | 171.4708914 | DE |
| 4 | 22.5 | 13.6363636364 | 165 | 187.5 | 142.5 | 20710 | 162.4102478 | DE |
| 12 | -35.5 | -15.9192825112 | 223 | 228 | 142.5 | 17205 | 184.14783708 | DE |
| 26 | 2.5 | 1.35135135135 | 185 | 233 | 89 | 51813 | 140.06653714 | DE |
| 52 | -72.5 | -27.8846153846 | 260 | 360 | 89 | 38692 | 152.81817276 | DE |
| 156 | -120 | -39.0243902439 | 307.5 | 392.5 | 89 | 21373 | 197.10914213 | DE |
| 260 | -115 | -38.0165289256 | 302.5 | 560 | 89 | 33513 | 293.12816027 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
